Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Breast cancer alters specific molecular structures in hair, which revert after cancer removal.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Tirzepatide may improve hair loss by reducing insulin resistance.

Mutations in the hairless protein gene cause hair loss.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Trichohyalin, a protein from pig tongue, was purified and found to have a filamentous structure.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Hair thinning and loss in a girl with a rare metabolic disorder was linked to her condition.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Hair restoration surgery can change the appearance of hair when examined with a special magnifying tool.

Identical twins with a rare KRT 86 gene mutation both have the hair disorder monilethrix.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.